Chance meeting five years ago leads to biotech startup CEO landing a Biogen biggie for her board

Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news